Showing results (251-260 of 686) with videos related to
Sort By:
Pageof 69
Molecular Cancer Therapeutics|October 17, 2007
O6-methylguanine-DNA-methyltransferase promoter demethylation is involved in basic fibroblast growth factor induced resistance against temozolomide in human melanoma cellsDennis Fontijn, Auke D Adema, Kishor K Bhakat, et al.FEBS Letters|August 18, 1997
Modulation by (iso)flavonoids of the ATPase activity of the multidrug resistance proteinJ H Hooijberg, H J Broxterman, M Heijn, et al.Free Radical Research Communications|January 1, 1986
Free radical formation from the antineoplastic agent VP 16-213J M Van Maanen, C De Ruiter, P R Kootstra, et al.European Journal of Cancer (Oxford, England : 1990)|November 3, 1998
Postconfluent multilayered cell line cultures for selective screening of gemcitabineE Smitskamp-Wilms, H M Pinedo, G Veerman, et al.Cancer Research|January 1, 1985
Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenograftsE Boven, W J van der Vijgh, M M Nauta, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Dose-finding study of the multitargeted tyrosine kinase inhibitor SU6668 in patients with advanced malignanciesBart C Kuenen, Giuseppe Giaccone, Rita Ruijter, et al.International Journal of Cancer|March 3, 2007
Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression after administration of 5-fluorouracil to patients with colorectal cancerRobert Mauritz, Cees J van Groeningen, Kees Smid, et al.Journal of Chromatography. B, Biomedical Applications|December 15, 1995
Quantification of paclitaxel metabolites in human plasma by high-performance liquid chromatographyM T Huizing, A Sparreboom, H Rosing, et al.European Journal of Cancer & Clinical Oncology|April 1, 1987
Phase II study of iproplatin (CHIP, JM-9) in advanced squamous cell carcinoma of the head and neckR Abele, M Clavel, S Monfardini, et al.Cancer Chemotherapy and Pharmacology|January 1, 1987
Potentiation of doxorubicin cytotoxicity by the calcium antagonist bepridil in anthracycline-resistant and -sensitive cell lines. A comparison with verapamilG J Schuurhuis, H J Broxterman, J J van der Hoeven, et al.Pageof 69